Quality of life and outcomes in African Americans with CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1849-1855

  Porter, Anna ^a   Fischer, Michael J ^a,b   Wang, Xuelei ^c   Brooks, Deborah ^d   Bruce, Marino ^e   Charleston, Jeanne ^f   Cleveland, William H ^g   Dowie, Donna ^h   Faulkner, Marquetta ⁱ   Gassman, Jennifer ^c   Hiremath, Leena ^j   Kendrick, Cindy ^c   Kusek, John W ^k   Norris, Keith C ^l   Thornley Brown, Denyse ^m   Greene, Tom ⁿ   Lash, James P ^a  

^a UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^b HINES VA HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e JACKSON STATE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MOREHOUSE SCHOOL OF MEDICINE   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ MEHARRY MEDICAL COLLEGE   (United States)

^j THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^l CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^m University of Alabama at Birmingham   (United States)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ADVERSE OUTCOME; AFRICAN AMERICAN; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; AGED; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; ETHNOLOGY; HEALTH STATUS; MIDDLE AGED; MORTALITY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AGED; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84921681693     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013080835     Document Type: Article

References (27)

1. Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB; HEMO Study Group: Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int 66: 355-366, 2004
2. Walters BAJ, Hays RD, Spritzer KL, Fridman M, Carter WB: Healthrelated quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis 40: 1185-1194, 2002
3. Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J: Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl Res 159: 4-11, 2012
4. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64: 339-349, 2003 doi: 10.1046/j.1523-1755.2003.00072.x
5. Lopes AA, Bragg-Gresham JL, Satayathum S, McCullough K, Pifer T, Goodkin DA, Mapes DL, Young EW, Wolfe RA, Held PJ, Port FK; Worldwide Dialysis Outcomes and Practice Patterns Study Committee: Healthrelated quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).AmJ KidneyDis 41: 605-615, 2003
6. Knight EL,Ofsthun N, Teng M, Lazarus JM, Curhan GC: The association between mental health, physical function, and hemodialysis mortality. Kidney Int 63: 1843-1851, 2003
7. Lowrie EG, Curtin RB, LePain N, Schatell D: Medical outcomes study short form-36: A consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 41: 1286-1292, 2003
8. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12: 2797-2806, 2001
9. Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Finkelstein FO: Health-related quality of life in CKD Patients: Correlates and evolution over time. Clin J Am Soc Nephrol 4: 1293-1301, 2009
10. Tsai Y-C, Hung C-C, Hwang S-J, Wang SL, Hsiao SM, Lin MY, Kung LF, Hsiao PN, Chen HC: Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant 25: 1621-1626, 2010
11. Fukuhara S, Yamazaki S,Marumo F, Akiba T, Akizawa T, Fujimi S, Haruki S, Kawaguchi Y, Nihei H, Shoji T,Maeda T: Health-related quality of life of predialysis patients with chronic renal failure. Nephron Clin Pract 105: c1-c8, 2007
12. Centers for Disease Control and Prevention (CDC): Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morb Mortal Wkly Rep 56: 161-165, 2007
13. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J: End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277: 1293-1298, 1997
14. Kusek JW, Greene P, Wang S-R, Beck G, West D, Jamerson K, Agodoa LY, Faulkner M, Level B: Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: The African American Study of KidneyDisease andHypertension Trial.AmJ Kidney Dis 39: 513-524, 2002
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
16. Lett HS, Blumenthal JA, BabyakMA, Sherwood A, Strauman T, Robins C, Newman MF: Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med 66: 305-315, 2004
17. Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, Covinsky KE: Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285: 2987-2994, 2001
18. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK Study Group: Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int 80: 670-678, 2011
19. Menon V, Gul A, Sarnak MJ: Cardiovascular risk factors in chronic kidney disease. Kidney Int 68: 1413-1418, 2005
20. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
21. Greene T: Randomized and observational studies in nephrology: How strong is the evidence? Am J Kidney Dis 53: 377-388, 2009
22. Appel LJ,Middleton J, Miller ER 3rd, LipkowitzM,Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT: The rationale and design of the AASK cohort study. J Am Soc Nephrol 14[Suppl 2]: S166-S172, 2003
23. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
24. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr; African-American Study of Hypertension and Kidney Disease: Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 38: 744-753, 2001
25. Ware JE Jr, Sherbourne CD: TheMOS 36-itemshort-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483, 1992
26. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32: 40-66, 1994
27. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr,Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group: Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48: 739-751, 2006 doi: 10.1053/j.ajkd.2006.08.004